SOUTH SAN FRANCISCO, CA--(Marketwire - May 16, 2008) - Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that three abstracts summarizing data from clinical trials relating to its oncology programs are planned to be presented at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, May 30-June 3, 2008. Two of these abstracts relate to clinical trials evaluating ispinesib that are sponsored by Cytokinetics or the National Cancer Institute (NCI). The third abstract relates to a clinical trial evaluating SB-743921 that is sponsored by Cytokinetics.
